EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Polypharmacy following Dementia Diagnoses in Vietnam: Results from Real-World Data in Outpatient Settings

Minh Tuan Hoang, Ngoc Thi Le, Thu Thi Hoai Nguyen, Thuy-Dung Nguyen, Thanh Xuan Nguyen, Anh Ngoc Nguyen, Thu Kim Dang, Binh Thanh Nguyen, Huong Thi Thanh Nguyen, Thang Pham, Anh Trung Nguyen, Tuan Anh Nguyen und 1 weitere

Gerontology · 2025

DOI: 10.1159/000550017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, 2025. Verfasst von Minh Tuan Hoang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden, minhtuan.hoang@ki.se. Hauptthemen laut MEDLINE: Polypharmacy, Dementia, Inappropriate Prescribing. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polypharmacy might be clinically appropriate if it improves health outcomes of people with dementia. However, polypharmacy was associated with higher risks of impairment in cognitive, physical, and emotional abilities. Several studies on polypharmacy among people with dementia were performed globally but not in Vietnam. This study aimed to investigate the epidemiology of polypharmacy among people with dementia in Vietnam.

Methods

This retrospective cohort study included outpatient individuals who were diagnosed with dementia between January 1, 2023, and April 15, 2024, in the Vietnam National Geriatric Hospital. Data were extracted from medical records, including dementia diagnosis, drug utilization, medical history before dementia diagnosis, comorbidities, and sociodemographic. The monthly quantity of drugs used was categorized as “no polypharmacy” 0–4 drugs, “polypharmacy” ≥5 drugs, and “hyperpolypharmacy” ≥10 drugs. The primary outcome was the incidence of polypharmacy following dementia diagnosis. The prescription of potentially inappropriate medications in people with dementia, identified using the American Geriatrics Society Beers criteria, was also evaluated. Multivariable logistic regression was employed to find associated risk factors of polypharmacy.

Results

During the follow-up from dementia diagnosis to June 30, 2024, there were 64 people having polypharmacy (median age at dementia diagnosis 73.5, 68.8% females) and 342 people without polypharmacy (median age at dementia diagnosis 74.0, 64.0% females). Age at dementia diagnosis, sex, regions of residence, and education were not associated with having polypharmacy in people with dementia. Compared to people with Alzheimer’s disease, significantly higher probabilities of having polypharmacy were seen in people with vascular dementia (odds ratio [OR] 4.63, 95% confidence interval [CI] 2.16–9.92) and other dementias (OR 4.61, 95% CI 2.31–9.18). People with dementia at severe stage were at lower chance of having polypharmacy (OR 0.19, 95% CI 0.05–0.63). Potentially inappropriate medications were more frequent in the polypharmacy group (n = 27, 42.2%), compared to the non-polypharmacy group (n = 59, 17.3%). Prescribing antipsychotics in the polypharmacy group doubled that in the non-polypharmacy group (34.4% versus 16.1%).

Conclusion

Lower incidence of polypharmacy among people with dementia compared to previous studies might either imply the improvement in managing the prescription of potentially inappropriate medications or be underestimated by not including inpatient individuals. Future studies are necessary to clarify the impact of polypharmacy on health outcomes of people with dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolypharmacyDementiaInappropriate PrescribingHumansMaleFemaleAgedRetrospective StudiesVietnamAged, 80 and overRisk FactorsPotentially Inappropriate Medication ListOutpatients

Stichwörter der Autor:innen

DementiaDrug utilizationEpidemiologyNeurologyPolypharmacyPotentially inappropriate medications

Autor:innen und Institutionen

  • Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden, minhtuan.hoang@ki.se.
  • Faculty of Public Health, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam, minhtuan.hoang@ki.se.
  • National Geriatric Hospital, Hanoi, Vietnam.
  • Neurology Department, Hanoi Medical University, Hanoi, Vietnam.
  • Geriatrics Department, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • NIA NIH HHS

Zitieren

APA

Hoang, M. T., Le, N. T., Hoai Nguyen, T. T., Nguyen, T. D., Nguyen, T. X., Nguyen, A. N., Dang, T. K., Nguyen, B. T., Thanh Nguyen, H. T., Pham, T., Nguyen, A. T., Nguyen, T. A., & Thanh Vu, H. T. (2025). Polypharmacy following Dementia Diagnoses in Vietnam: Results from Real-World Data in Outpatient Settings. Gerontology. https://doi.org/10.1159/000550017

Vancouver

Hoang MT, Le NT, Hoai Nguyen TT, Nguyen TD, Nguyen TX, Nguyen AN, et al. Polypharmacy following Dementia Diagnoses in Vietnam: Results from Real-World Data in Outpatient Settings. Gerontology. 2025. doi:10.1159/000550017

BibTeX
@article{Hoang2025,
  author = {Hoang, Minh Tuan and Le, Ngoc Thi and Hoai Nguyen, Thu Thi and Nguyen, Thuy-Dung and Nguyen, Thanh Xuan and Nguyen, Anh Ngoc and Dang, Thu Kim and Nguyen, Binh Thanh and Thanh Nguyen, Huong Thi and Pham, Thang and Nguyen, Anh Trung and Nguyen, Tuan Anh and Thanh Vu, Huyen Thi},
  title = {Polypharmacy following Dementia Diagnoses in Vietnam: Results from Real-World Data in Outpatient Settings},
  journal = {Gerontology},
  year = {2025},
  doi = {10.1159/000550017}
}
Kostenlos starten →